Eli Lilly is getting a foothold in messenger RNA (mRNA) cancer vaccines through a deal with CureVac that could develop up to five new therapies.
Join Xconomy for its second annual cybersecurity event on December 5 at WGBH. This year, we will discuss how Boston-area cybersecurity companies are working to advance the state of the art in security automation, behavioral analytics, anti-phishing systems, and other arenas,... Read more »
In advance of an anticipated Senate hearing on drug prices, President Donald Trump once again denounced drug companies as “getting away with murder.” The first time he did so, using the same phrase just before his inauguration, the markets shuddered.... Read more »
Bridj, the Boston-based, app-enabled transit service that shut down in the spring, is apparently making a comeback—in Australia.
This week in Boston tech, we’re tracking another new growth equity fund focused on healthcare and software, acquisitions by Akamai Technologies and Grapevine, layoffs at video game maker Disruptor Beam, DraftKings’ expansion, and more. Read on for details.
—There’s another new... Read more »
Whether it’s drug companies trying to harness machine learning or doctors using software to make diagnoses, artificial intelligence is moving into healthcare—and moving fast.
On November 2, Xconomy is gathering an elite group of technology and medical leaders to map out... Read more »
Digital technologies have helped create immense wealth and societal progress, but not everyone has shared in that prosperity.
KalVista Pharmaceuticals has inked a partnership with pharmaceutical giant Merck for its lead drug, an experimental treatment for a complication of diabetes that can lead to blindness.
In mid-October, eleven college students will be flying to California for an opportunity that would be the envy of any Ivy League MBA candidate—they’ll meet the venture capital firm partners who will personally mentor them throughout the school year.
The students—all... Read more »
Steve Case, venture capitalist, author, and co-founder of AOL, is preparing to hit the road this week on his sixth Rise of the Rest tour, where he travels to emerging innovation hubs in search of investment-worthy tech startups and to highlight... Read more »
Xconomy’s annual Boston’s Life Science Disruptors event on September 28th in Kendall Square brought a packed house to Pfizer. Attendees heard candid stories from some of Boston’s most disruuptive biotech company leaders, founders, and VC backers.
We presented three stories this... Read more »
CEO and President, Carbonite
Co-founder, Chairman, and CEO, Flex Pharma
CEO, Editas Medicine
Founder and CEO of Kiva Systems
Writer and Consultant
Managing Director, CommonAngels Ventures
Partner, Nixon Peabody LLP
President and Founder at Co-Flow Investing
Founder and Managing Partner, Boston Millennia Partners